Harvey, B K <br/><br/>
HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury.  [electronic resource] 

 -  Experimental neurology  Sep 2003 
 - 47-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-4886 
<br/><br/><label>Standard No.: </label>10.1016/s0014-4886(03)00080-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Astrocytes--drug effects<br/>Brain--blood supply<br/>Caspase 3<br/>Caspases--metabolism<br/>Cells, Cultured<br/>Disease Models, Animal<br/>Genetic Therapy--methods<br/>Genetic Vectors--administration & dosage<br/>Glial Cell Line-Derived Neurotrophic Factor<br/>Glial Fibrillary Acidic Protein--metabolism<br/>Hydrogen Peroxide--toxicity<br/>Immunohistochemistry<br/>Ischemic Attack, Transient--pathology<br/>Motor Activity--drug effects<br/>Nerve Growth Factors--administration & dosage<br/>Neurons--drug effects<br/>Neuroprotective Agents--administration & dosage<br/>Oxidants--toxicity<br/>Rats<br/>Rats, Sprague-Dawley<br/>Recovery of Function<br/>Simplexvirus--genetics<br/>Treatment Outcome